ReviewTherapeutics and clinical risk management2023
Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder.
Christina Shaw et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it